Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals - Wikidata - awgldk - TriplyDB

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals

http://www.wikidata.org/entity/Q33864775

about

The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cells Immune evasion and recognition of the syphilis spirochete in blood and skin of secondary syphilis patients: two immunologically distinct compartments Licensed and Unlicensed NK Cells: Differential Roles in Cancer and Viral Control NK Cells in HIV Disease The role of NK cells in HIV-1 protection: autologous, allogeneic or both?Innate immune cells in liver inflammation Evasion from NK cell-mediated immune responses by HIV-1 NK Cell Influence on the Outcome of Primary Epstein-Barr Virus Infection Features of Memory-Like and PD-1(+) Human NK Cell Subsets γδ T Cells in HIV Disease: Past, Present, and Future IL-21 enhances NK cell functions and survival in healthy and HIV-infected patients with minimal stimulation of viral replication Decreased NK Cell FcRgamma in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional study Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiency.HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response Alcohol suppresses IL-2-induced CC chemokine production by natural killer cells.NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection.Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfection Persistence of Activated and Adaptive-Like NK Cells in HIV+ Individuals despite 2 Years of Suppressive Combination Antiretroviral Therapy.IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissues.HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma Interferon-alpha administration enhances CD8+ T cell activation in HIV infection Increased frequency and function of KIR2DL1-3⁺ NK cells in primary HIV-1 infection are determined by HLA-C group haplotypes.Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.Loss of CCR7 expression on CD56(bright) NK cells is associated with a CD56(dim)CD16⁺ NK cell-like phenotype and correlates with HIV viral load.Changes in Natural Killer cell activation and function during primary HIV-1 Infection.Natural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infection NK cells and their ability to modulate T cells during virus infections Simian immunodeficiency virus (SIV)/immunoglobulin G immune complexes in SIV-infected macaques block detection of CD16 but not cytolytic activity of natural killer cells Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults Immune markers predictive of neuropsychiatric symptoms in HIV-infected youth.Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure Mutiny or scrutiny: NK cell modulation of DC function in HIV-1 infection.

P2860

Q21144323-8D986361-D134-4D89-AED2-CCD9C2E7CFC5 Q21144775-EDDE0288-D8F2-493B-A5DA-58A7BC6D6021 Q26747397-BA86F2C4-DDA7-451C-A377-53C9AEFD5E01 Q26752833-045F846F-945B-49C8-AB9F-8181AC1F08EC Q26753146-A1CB8652-9140-4B10-8499-DF6A7A021453 Q26859951-E6D9CC3F-8957-4902-ABF7-5980C3E644C1 Q26864489-694E58FE-2D1D-4D61-A21A-9446358DEDCA Q28069456-9961CEF9-5973-4B91-9279-1F711663F9C4 Q28073988-0E719F20-B052-4494-8F47-8A1AE46951B6 Q28084822-4921E1E9-BF7D-495E-8F5B-64BFBC7F8D36 Q28271479-21A43B97-D7F4-4DFC-AE7E-B19E9FF6BF4D Q28473151-B0004ED7-352B-47DC-A288-62F88A79AA88 Q30845033-EE642348-8699-4E00-B3CA-43991A7C71EA Q33302895-635719DE-C080-4586-94BA-76BC1B84FDCB Q33508241-8E83AE22-DAE5-4EFC-AC3B-27176B7E943F Q33586473-27F5ADBE-BB56-4A39-88C9-65B5D260212B Q33741498-D908FEB5-E37E-425E-A3F5-315F151FF17D Q33752757-24748E3F-6D5C-40C2-959C-F9C8CA5537AC Q33772422-C8D6A90D-FEA4-4A67-9EE1-804EDE2E8FB9 Q33831703-F1A7AFDA-2991-4BFE-B8F1-C667E10ABAD9 Q33854427-708BAE9C-1B6E-4D5F-9193-8E5F3560E167 Q33882890-5A3CC5BD-E892-45A3-B660-0D776622EAEB Q34037685-C79F55BD-E03A-45A3-AB90-1382AEEB1759 Q34087961-676E2C67-F721-4C14-9BC8-2FB745B1E2DB Q34087997-78DF10EC-462F-4DE4-B38C-A9D0ECD25257 Q34130226-C1DAB59D-A2C8-42D0-B2C0-E649C83CA6C2 Q34145979-3ECF1790-77B7-4241-A7CD-72DABBFBC2B3 Q34339253-9EFD448F-B616-4E4A-83AA-6F52425D3237 Q34400439-45958278-8BDC-4556-B0A2-6ED2299AF86E Q34427488-BB803B3B-0311-4D75-94A6-A812E2972F67 Q34551274-BA283381-9858-41C5-B25E-038E66BF8FB2 Q34694776-122F19C1-8B95-4A61-AC5F-B7E6291EB617 Q34700499-2C0D3A10-205E-46BC-8BFC-BEA1475EE0D5 Q34720432-6DE2A5E3-0BD2-4FCD-A285-662D843601DF Q34741864-2DCE8D96-66EF-41FB-B318-8DF57F16A202 Q34765436-9369C83A-034F-46DC-A0EF-F06C44D6D11F Q34784984-A78D0A72-00C3-4AA7-A606-73370C491E36 Q34785742-18A9BF44-2F67-4DA5-B991-26A0C0748EAD Q34937296-A8988289-ED17-4DC7-9EB0-234E75363039 Q34959053-DC59F3C7-F795-4F29-BD6B-D8A315D6974A

P2860

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals

http://www.wikidata.org/entity/Q33864775

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Characterization of CD56-/CD16 ...... V-infected viremic individuals

@ast

Characterization of CD56-/CD16 ...... V-infected viremic individuals

@en

type

label

Characterization of CD56-/CD16 ...... V-infected viremic individuals

@ast

Characterization of CD56-/CD16 ...... V-infected viremic individuals

@en

prefLabel

Characterization of CD56-/CD16 ...... V-infected viremic individuals

@ast

Characterization of CD56-/CD16 ...... V-infected viremic individuals

@en

P1433

Q33864775-F4A96B0B-20F7-488C-B57C-71CF730AD77B

P1476

Q33864775-F0A456D2-4127-4CF8-9EF0-36AAA12F5016

P2093

Q33864775-1B4FF972-3356-4FCC-B3C5-5A491E685B49

Q33864775-2EB77D54-D489-4AC3-8B11-3E388F971CC1

Q33864775-2F9FA12A-36AE-495C-8D39-BB88536AE2F0

Q33864775-34FD1794-3EE0-4AE4-B197-0070C32FA719

Q33864775-6100B45C-10CC-4994-9659-EFD5F3A411E5

Q33864775-7EBEA010-5CE9-403C-AD01-90EC97B55679

Q33864775-974C08DF-996C-4D3C-AD40-D300FFC52EAC

Q33864775-ACAC9232-FFF7-4848-8066-AF94B9B19E97

Q33864775-B89BF2FF-C6A7-4283-88BF-97EC32274777

P2860

Q33864775-1358DB75-D9C4-49C5-9004-8E4FCDE94FA2

Q33864775-14B672AA-8635-4CFA-83B5-2334299B55EA

Q33864775-331F8839-BCC1-4EE1-88C5-8E2006290B47

Q33864775-34F7AD88-6C47-40EB-8216-A3F46959CE69

Q33864775-4007F239-68DC-4C82-80D0-017661FF7914

Q33864775-4258E566-0F48-470B-BDC3-914F094B6237

Q33864775-4BC8ADB2-C9B5-4BE9-BD32-889D3C50CF33

Q33864775-4C398789-6EAA-4A41-94B7-EAA33E4574A1

Q33864775-67C5FD27-D52C-4B08-A9D0-296BCAB19A9D

Q33864775-6C6AD893-E0EE-4CC2-ABEF-9DE07D32B5FF

P304

Q33864775-F30FE128-A8A9-41AB-9F71-9FD8608FEE8C

P31

Q33864775-3AF48018-9CBB-43EC-B02F-9EAF66AB5201

P356

Q33864775-840CD46A-0EEA-45FB-9D05-3D9B5A535D82

P407

Q33864775-492FFDC1-E760-4915-B5B9-3F51D5F128C7

P433

Q33864775-53608C34-6000-42DC-A29A-31106AB5EC9F

P478

Q33864775-A35964F4-E453-4368-A964-B63B308F0FC9

P50

Q33864775-7FE78D96-3E3F-4493-A730-BCA0888A3343

Q33864775-F0BD33A9-7AAC-491D-9086-8B5C420F6882

P577

Q33864775-6E5F9462-AE83-47ED-98AB-D33F5535DCA6

P5875

Q33864775-D933116B-64F3-463C-92F3-9A950227E615

P698

Q33864775-8A88D20C-3B52-4A79-9A03-58392CB0C247

P932

Q33864775-0972FA66-DD02-4EB2-8EB4-8C15CBD7F5DE

P356

PNAS.0409872102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Characterization of CD56-/CD16 ...... V-infected viremic individuals

@en

P2093

Alessandro Moretta

http://www.w3.org/2001/XMLSchema#string

Audrey Kinter

http://www.w3.org/2001/XMLSchema#string

Colin Kovacs

http://www.w3.org/2001/XMLSchema#string

Dean Follman

http://www.w3.org/2001/XMLSchema#string

Diana Kim

http://www.w3.org/2001/XMLSchema#string

Emanuela Marcenaro

http://www.w3.org/2001/XMLSchema#string

Gabriella Lombardo

http://www.w3.org/2001/XMLSchema#string

Janet Benjamin

http://www.w3.org/2001/XMLSchema#string

M Angeline O'Shea

http://www.w3.org/2001/XMLSchema#string

P2860

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

Role of chemokines in the biology of natural killer cells

Biology of natural killer cells

Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease

Natural killer cells, viruses and cancer.

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates.

The biology of human natural killer-cell subsets.

P304

2886-2891

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0409872102

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Domenico Mavilio

P577

2005-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8034025

http://www.w3.org/2001/XMLSchema#string

P698

15699323

http://www.w3.org/2001/XMLSchema#string

P932

549494

http://www.w3.org/2001/XMLSchema#string